Annual SG&A
$40.58 M
+$16.72 M+70.07%
31 December 2023
Summary:
Cartesian Therapeutics annual selling, general & administrative expenses is currently $40.58 million, with the most recent change of +$16.72 million (+70.07%) on 31 December 2023. During the last 3 years, it has risen by +$21.67 million (+114.57%). RNAC annual SG&A is now at all-time high.RNAC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.56 M
-$465.00 K-6.62%
01 September 2024
Summary:
Cartesian Therapeutics quarterly selling, general & administrative expenses is currently $6.56 million, with the most recent change of -$465.00 thousand (-6.62%) on 01 September 2024. Over the past year, it has dropped by -$52.00 thousand (-0.79%). RNAC quarterly SG&A is now -70.40% below its all-time high of $22.17 million, reached on 31 December 2023.RNAC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.63 B
-$244.83 M-10.28%
01 September 2024
Summary:
Cartesian Therapeutics TTM selling, general & administrative expenses is currently -$2.63 billion, with the most recent change of -$244.83 million (-10.28%) on 01 September 2024. Over the past year, it has dropped by -$2.65 billion (-10713.51%). RNAC TTM SG&A is now -2254.60% below its all-time high of $45.26 million, reached on 30 June 2024.RNAC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.1% | -0.8% | -10000.0% |
| 3 y3 years | +114.6% | +20.5% | -10000.0% |
| 5 y5 years | +122.5% | +77.8% | -10000.0% |
RNAC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +114.6% | -70.4% | +20.5% | -65.1% | at low |
| 5 y | 5 years | at high | +147.6% | -70.4% | +77.8% | -118.3% | at low |
| alltime | all time | at high | +410.3% | -70.4% | +250.5% | -2254.6% | at low |
Cartesian Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.56 M(-6.6%) | $45.21 M(-0.1%) |
| June 2024 | - | $7.03 M(-25.6%) | $45.26 M(+2.1%) |
| Mar 2024 | - | $9.45 M(-57.4%) | $44.34 M(+9.3%) |
| Dec 2023 | $40.58 M(+70.1%) | $22.17 M(+235.2%) | $40.58 M(+64.0%) |
| Sept 2023 | - | $6.61 M(+8.3%) | $24.74 M(+3.5%) |
| June 2023 | - | $6.11 M(+7.2%) | $23.89 M(-0.5%) |
| Mar 2023 | - | $5.70 M(-9.9%) | $24.02 M(+0.7%) |
| Dec 2022 | $23.86 M(+14.0%) | - | - |
| Dec 2022 | - | $6.32 M(+9.6%) | $23.86 M(+3.4%) |
| Sept 2022 | - | $5.77 M(-7.4%) | $23.08 M(+1.4%) |
| June 2022 | - | $6.23 M(+12.5%) | $22.75 M(+7.0%) |
| Mar 2022 | - | $5.54 M(-0.1%) | $21.27 M(+1.6%) |
| Dec 2021 | $20.94 M(+10.7%) | $5.54 M(+1.8%) | $20.94 M(+3.9%) |
| Sept 2021 | - | $5.45 M(+14.7%) | $20.16 M(+5.4%) |
| June 2021 | - | $4.75 M(-8.8%) | $19.13 M(-4.4%) |
| Mar 2021 | - | $5.20 M(+9.4%) | $20.02 M(+5.8%) |
| Dec 2020 | $18.91 M(+15.4%) | $4.76 M(+7.6%) | $18.91 M(+3.8%) |
| Sept 2020 | - | $4.42 M(-21.6%) | $18.23 M(+4.2%) |
| June 2020 | - | $5.64 M(+37.6%) | $17.50 M(+9.5%) |
| Mar 2020 | - | $4.10 M(+0.6%) | $15.97 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $16.39 M(-10.1%) | $4.07 M(+10.4%) | $16.39 M(-6.2%) |
| Sept 2019 | - | $3.69 M(-10.3%) | $17.46 M(-2.1%) |
| June 2019 | - | $4.11 M(-8.8%) | $17.83 M(-1.4%) |
| Mar 2019 | - | $4.51 M(-12.3%) | $18.08 M(-0.9%) |
| Dec 2018 | $18.24 M(-3.1%) | $5.15 M(+26.9%) | $18.24 M(-2.8%) |
| Sept 2018 | - | $4.06 M(-7.0%) | $18.76 M(-1.7%) |
| June 2018 | - | $4.36 M(-6.7%) | $19.08 M(-2.8%) |
| Mar 2018 | - | $4.67 M(-17.6%) | $19.63 M(+4.2%) |
| Dec 2017 | $18.83 M(+44.2%) | $5.67 M(+29.6%) | $18.83 M(-0.5%) |
| Sept 2017 | - | $4.38 M(-10.7%) | $18.91 M(+11.1%) |
| June 2017 | - | $4.90 M(+26.5%) | $17.03 M(+17.1%) |
| Mar 2017 | - | $3.88 M(-32.7%) | $14.54 M(+11.4%) |
| Dec 2016 | $13.05 M(+56.6%) | $5.76 M(+130.7%) | $13.05 M(+40.0%) |
| Sept 2016 | - | $2.50 M(+3.2%) | $9.32 M(+3.3%) |
| June 2016 | - | $2.42 M(+1.6%) | $9.02 M(+2.0%) |
| Mar 2016 | - | $2.38 M(+17.3%) | $8.84 M(+6.1%) |
| Dec 2015 | $8.34 M(+4.8%) | $2.03 M(-7.5%) | $8.34 M(+32.2%) |
| Sept 2015 | - | $2.19 M(-1.9%) | $6.30 M(+53.4%) |
| June 2015 | - | $2.24 M(+19.6%) | $4.11 M(+119.6%) |
| Mar 2015 | - | $1.87 M | $1.87 M |
| Dec 2014 | $7.95 M | - | - |
FAQ
- What is Cartesian Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual SG&A year-on-year change?
- What is Cartesian Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly SG&A year-on-year change?
- What is Cartesian Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM SG&A year-on-year change?
What is Cartesian Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of RNAC is $40.58 M
What is the all time high annual SG&A for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual selling, general & administrative expenses is $40.58 M
What is Cartesian Therapeutics annual SG&A year-on-year change?
Over the past year, RNAC annual selling, general & administrative expenses has changed by +$16.72 M (+70.07%)
What is Cartesian Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of RNAC is $6.56 M
What is the all time high quarterly SG&A for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly selling, general & administrative expenses is $22.17 M
What is Cartesian Therapeutics quarterly SG&A year-on-year change?
Over the past year, RNAC quarterly selling, general & administrative expenses has changed by -$52.00 K (-0.79%)
What is Cartesian Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of RNAC is -$2.63 B
What is the all time high TTM SG&A for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM selling, general & administrative expenses is $45.26 M
What is Cartesian Therapeutics TTM SG&A year-on-year change?
Over the past year, RNAC TTM selling, general & administrative expenses has changed by -$2.65 B (-10713.51%)